Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
Pedro Machado(Fermi National Accelerator Laboratory), Claire Bombardier(Toronto General Hospital), E. Martín‐Mola(Hospital Universitario La Paz), R. B. M. Landewé(Maastricht University), Carlomaurizio Montecucco(University of Pavia), P Martínez-Osuna, Édith Villeneuve, Maria D. Mjaavatten(Diakonhjemmet Hospital), Wanruchada Katchamart(Mount Sinai Hospital), Vivian P. Bykerk(Hospital for Special Surgery), Anca I. Catrina(Karolinska University Hospital), Kristof Thevissen(Maastricht University), Helena Canhão(University of Lisbon), Benito R. Losada(Hospital Clínico Universitario de Caracas), Jane Zochling(Royal North Shore Hospital), Monika Schoels(Klinik Hietzing), Daniel Aletaha(Medical University of Vienna), Ward Vercoutere(Atrium Medisch Centrum Parkstad), Isabel Castrejón(Hospital Universitario de La Princesa), J. W. J. Bijlsma(University Medical Center Utrecht), Bindee Kuriya(Canadian Institutes of Health Research), Burkhard F. Leeb, Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Barry J. Sheane(St. James's Hospital), Rosanne Koevoets(Leiden University Medical Center), Ricardo Machado Xavier(Universidade Federal do Rio Grande do Sul), Patrick Durez(Cliniques Universitaires Saint-Luc), Lucía Silva-Fernández(Hospital Universitario Puerta de Hierro Majadahonda), Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), Loreto Carmona(Instituto de Salud Musculoesquelética), D. van der Heijde(Leiden University Medical Center), M. Østergaard(Hvidovre Hospital)
Cited by 72
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
|Arthritis & Rheumatism|2010|9.5k
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
|New England Journal of Medicine|2000|4k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k